Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia, a Comparative Study

NCT02021201 is registered in ClinicalTrials.gov with Birte Glenthoj as lead sponsor.

NCT NCT02021201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02021201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia, a Comparative Study
Lead sponsor
Birte Glenthoj
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2008
Completion date
July 31, 2013
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia